期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
沙利度胺联合FOLFIRI方案治疗晚期结肠直肠癌的临床观察 被引量:2
1
作者 王琼 许晨 +3 位作者 王南瑶 盛华明 费燕华 吴丹 《癌症进展》 2009年第4期460-461,471,共3页
目的观察沙利度胺联合FOLFIRI方案治疗晚期结直肠癌的疗效及安全性。方法26例符合入组条件的晚期结肠直肠癌患者采用伊立替康(CPT-11)+5-氟尿嘧啶(5-Fu)+亚叶酸钙(LV)方案(即FOLFIRI方案)联合沙利度胺化疗。结果本组CR3例,PR9例,NC8例,... 目的观察沙利度胺联合FOLFIRI方案治疗晚期结直肠癌的疗效及安全性。方法26例符合入组条件的晚期结肠直肠癌患者采用伊立替康(CPT-11)+5-氟尿嘧啶(5-Fu)+亚叶酸钙(LV)方案(即FOLFIRI方案)联合沙利度胺化疗。结果本组CR3例,PR9例,NC8例,有效率(CR+PR)为46.15%(12/26),临床获益率为76.92%;中位疾病进展时间(TTP)为4.5个月;主要毒副作用为恶心呕吐、粘膜炎、腹痛、腹泻、血液学毒性。结论沙利度胺联合FOLFIRI方案治疗晚期结肠直肠癌疗效确切,患者耐受性好。 展开更多
关键词 晚期结肠直肠癌 联合治疗 沙利度胺
下载PDF
微卫星不稳定状态对Ⅳ期结直肠癌患者化疗反应性和预后的影响 被引量:14
2
作者 吴宇辰 张长胜 +4 位作者 梁斐 黄丹 朱骥 徐烨 刘方奇 《中国癌症杂志》 CAS CSCD 北大核心 2015年第7期522-528,共7页
背景与目的:错配修复缺陷导致的微卫星不稳(microsatellite inistability,MSI)状态对Ⅱ、Ⅲ期结直肠癌患者的预后及化疗敏感性有重要作用,但在晚期肠癌中研究较少。该研究探讨微卫星不稳对晚期结直肠癌患者化疗敏感性及预后的影响。方法... 背景与目的:错配修复缺陷导致的微卫星不稳(microsatellite inistability,MSI)状态对Ⅱ、Ⅲ期结直肠癌患者的预后及化疗敏感性有重要作用,但在晚期肠癌中研究较少。该研究探讨微卫星不稳对晚期结直肠癌患者化疗敏感性及预后的影响。方法:收集采用XELOX或FOLFOX为一线化疗方案的Ⅳ期肠癌患者的原发肿瘤组织,免疫组化方法检测肿瘤组织中错配修复基因h MLH1、h MSH2、h MSH6和h PMS2的蛋白表达,分析微卫星状态与患者临床特征、预后及化疗反应的相关性。结果:共收集113例晚期结直肠癌患者,未发现MSI与患者总体生存时间(overall survival,OS)以及化疗敏感性存在相关。亚组分析中我们发现79例原发灶姑息性切除的患者中,MSI患者(22例)较MSS患者(57例)的中位无疾病进展时间(progression-free survival,PFS)明显延长(19.9个月vs 7个月,P=0.005),但MSI与OS无关(P=0.07)。对该79例患者预后行Cox多因素分析显示,MSI是影响患者PFS的独立危险因素(P=0.043,MSS/MSI,HR=2.079)。此外,该群患者的MSI状态与疾病控制率(59.1%vs31.6%,P=0.025)相关。结论:在原发灶姑息性切除的Ⅳ期结直肠癌患者中,微卫星不稳定状态与无疾病进展时间和化疗的疾病控制率呈正相关,因而有必要对该群患者进行微卫星检测。 展开更多
关键词 晚期结肠直肠癌 微卫星不稳定 化疗 预后
下载PDF
骶前直肠肿瘤的诊断与治疗仍面临挑战
3
作者 Glasgow S.C. Birnbaum E.H. +2 位作者 Lowney J.K. D.W. Dietz 廖新华 《世界核心医学期刊文摘(胃肠病学分册)》 2005年第12期17-18,共2页
PURPOSE: Tumors occurring in the retrorectal space are heterogeneous and uncommon. The utility of newer imaging techniques has not been extensively described, and operative approach is variable. This study examined th... PURPOSE: Tumors occurring in the retrorectal space are heterogeneous and uncommon. The utility of newer imaging techniques has not been extensively described, and operative approach is variable. This study examined the diagnosis, treatment, and outcome of retrorectal tumors at a tertiary referral center. METHODS: Patients with primary, extramucosal neoplasms occurring in the retrorectal space were identified using a prospectively maintained, procedural database of all adult colorectal surgical patients (1981- 2003). Patients also were incorporated from the gynecologic oncology service. Exclusion criteria included inflammatory processes, locally advanced colorectal cancer, and metastatic malignancy. Medical records, radiology, and pathology reports were reviewed retrospectively. RESULTS: Thirty- four patients with retrorectal tumors were treated. Malignant tumors comprised 21 percent. Older age, male gender, and pain were predictive of malignancy (P < 0.05). Sensitivity of proctoscopy was 53 percent; this increased to 100 percent with the use of transrectal ultrasound. Accuracy of magnetic resonance vs. computed tomographic imaging for specific histologic tumor type was 28 vs. 18 percent, respectively. Surgical approach was anterior (n=14), posterior (n=11), and combined abdomin- operineal (n=9). Eleven patients required en bloc proctectomy. Patients undergoing posterior resection had lower blood loss and required fewer transfusions (P < 0.05). All benign tumors were resected with normal histologic margins and none recurred (median follow- up, 22 months). All patients with malignancy had recurrence/recrudescence of their disease. For these patients, median disease- free and overall survivals were 38 and 61 months, respectively. CONCLUSIONS: Retrorectal tumors remain a diagnostic and therapeutic challenge. Pain, male gender, and advanced age increase the likelihood of malignancy. Various imaging modalities are useful for planning resection but cannot establish a definitive diagnosis. Whereas benign retrorectal tumors can be completely resected, curative resection of malignant retrorectal tumors remains difficult. 展开更多
关键词 直肠肿瘤 晚期结肠直肠癌 直肠镜检 结肠直肠手术 成人患者 前间隙 三级医疗 无瘤生存 切缘 妇科肿瘤患者
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部